Using Machine Learning to Model Early-onset Neonatal Sepsis Risk in Uganda and Zimbabwe
Key facts
- Who runs it
- St George's, University of London
- Where
- Uganda and United Kingdom2 sites in 2 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 1,559 people enrolled
- Started
- 11 Apr 2024
- Ended
- 25 Sept 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- Maternal medical history
- Record updated
- 17 November 2026
Who can take part
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Neonates born at one of the study sites
- Neonates born at ≥34 weeks gestational age, defined by:
- Ultrasound scan, where participant has had an ultrasound scan during routine antenatal care
- If no ultrasound scan has been done, according to last menstrual period date, according to mother
- If no ultrasound scan has been done and the mother does not know her last menstrual period date, the neonate will be eligible for inclusion if their birth weight is ≥1400g which will include the majority of births ≥34 weeks according to the results of the INTERGROWTH-21st Project(44)
Who cannot take part
- Neonates with congenital abnormalities or syndromes associated with increased susceptibility to infection will be excluded (e.g. gastroschisis)
- Neonates born at <34 weeks gestational age, due to their higher background risk of sepsis, and automatic admission to the neonatal unit with antibiotic administration
- Neonates whose mothers are unable to provide informed consent
Where is this trial?
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this observational study is to develop a risk prediction model for early-onset neonatal sepsis in term and late preterm neonates in Uganda and Zimbabwe.
Read full original descriptionShow less
The main questions it aims to answer are:
* What are the risk factors for early-onset neonatal sepsis in low-resource settings? * How can these be combined into a risk prediction model?
Mother-baby pairs will be recruited in Uganda. They will have extensive data taken on their medical and obstetric histories and lifestyles, and their newborns will have a blood sample taken just after birth for culture. Machine learning techniques will be used to create the risk prediction model, which will then be validated in a second population in Zimbabwe.
The 2 groups in the trial
- Ugandan mother-baby cohort
Mother-baby pairs recruited antenatally or at delivery, with babies eligible for inclusion if they are born at 34 weeks gestational age and above. Used as primary data for modelling.
Treatment: Maternal medical history
- Zimbabwean mother-baby cohort
Mother-baby pairs with babies eligible for inclusion if they are born at 34 weeks gestational age and above, used as a validation cohort for the model.
Treatment: Maternal medical history
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Using Machine Learning to Model Early-onset Neonatal Sepsis Risk in Late Preterm and Term Neonates in Uganda and Zimbabwe
- Record updated
- 17 November 2026